Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $58.00 USD
Change Today +0.57 / 0.99%
Volume 288.4K
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mary Lynne Hedley Ph.D.

Co-Founder, President, Chief Operating Officer and Director, Tesaro, Inc.
AgeTotal Calculated CompensationThis person is connected to 43 board members in 2 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Mary Lynne Hedley, Ph.D. founded Tesaro, Inc. in March 2010 and has been its President since March 2010, and has been its Chief Operating Officer since July 24, 2014. Dr. Hedley served as the Chief Scientific Officer of Tesaro, Inc. since March 2010 until July 24, 2014. Dr. Hedley served as the Chief Scientific Officer and Executive Vice President of Operations at Abraxis BioScience, Inc. from July 2009 to February 2010. She served as the Chief Executive Officer, ...

Read Full Background

Corporate Headquarters*

1000 Winter Street
Waltham, Massachusetts 02451

United States

Phone: 339-970-0900
Fax: --

Board Members Memberships*

Co-Founder, President, Chief Operating Officer and Director
Director and Member of Compensation Committee


Post-Doctoral Training 1996
Harvard University
Purdue University
University of Texas Southwestern Medical Center - Dallas

Other Affiliations*

Annual Compensation*

Total Annual Compensation$462,000

Stock Options*

All Other Compensation$12,634
Exercisable Options556,322
Exercisable Options Value$16,954,522
Unexercisable Options352,249
Unexercisable Options Value$6,413,035
Total Value of Options$23,367,556
Total Number of Options908,571

Total Compensation*

Total Annual Cash Compensation$698,820
Total Short Term Compensation$462,000
Other Long Term Compensation$12,634
Total Calculated Compensation$3,051,923
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TSRO:US $58.00 USD +0.57


Barry D. Quart Pharm.D.Chief Executive Officer and Director
Heron Therapeutics, Inc.
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TESARO INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at